Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, today announces the launch of ‘Favivir’ (Favipiravir 200 mg) in India to treat mild to moderate Covid-19.
Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, today announces the launch of ‘Favivir’ (Favipiravir 200 mg) in India to treat mild to moderate Covid-19.
